BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35305591)

  • 1. Single-cell sequencing reveals MYC targeting gene MAD2L1 is associated with prostate cancer bone metastasis tumor dormancy.
    Wang X; Yu J; Yan J; Peng K; Zhou H
    BMC Urol; 2022 Mar; 22(1):37. PubMed ID: 35305591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development.
    Wei R; Wang Z; Zhang Y; Wang B; Shen N; E L; Li X; Shang L; Shang Y; Yan W; Zhang X; Ma W; Wang C
    BMC Med Genomics; 2020 Aug; 13(1):112. PubMed ID: 32795325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone.
    Sharma S; Xing F; Liu Y; Wu K; Said N; Pochampally R; Shiozawa Y; Lin HK; Balaji KC; Watabe K
    J Biol Chem; 2016 Sep; 291(37):19351-63. PubMed ID: 27422817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.
    Xiaoli Z; Yawei W; Lianna L; Haifeng L; Hui Z
    Med Sci Monit; 2015 Dec; 21():3748-59. PubMed ID: 26628405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAD2L1 Functions As a Novel Diagnostic and Predictive Biomarker in Cholangiocarcinoma.
    Gao Y; Liu Y; Sun L; Ouyang X; Zhu C; Qin X
    Genet Test Mol Biomarkers; 2021 Nov; 25(11):685-695. PubMed ID: 34788140
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dysregulation of MAD2L1/CAMK2A/PTTG1 Gene Cluster Maintains the Stemness Characteristics of Uterine Corpus Endometrial Carcinoma].
    Zheng J; Zhang YW; Pan ZF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Oct; 43(5):685-695. PubMed ID: 34728029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Spindle assembly checkpoint complex-related genes TTK and MAD2L1 are over-expressed in lung adenocarcinoma: a big data and bioinformatics analysis].
    Liu Z; Guo Z; Long L; Zhang Y; Lu Y; Wu D; Dong Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Oct; 40(10):1422-1431. PubMed ID: 33118511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and predictive values of CDK1 and MAD2L1 in lung adenocarcinoma.
    Shi YX; Zhu T; Zou T; Zhuo W; Chen YX; Huang MS; Zheng W; Wang CJ; Li X; Mao XY; Zhang W; Zhou HH; Yin JY; Liu ZQ
    Oncotarget; 2016 Dec; 7(51):85235-85243. PubMed ID: 27835911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII-p38MAPK-pS249/T252RB Pathway.
    Yu-Lee LY; Yu G; Lee YC; Lin SC; Pan J; Pan T; Yu KJ; Liu B; Creighton CJ; Rodriguez-Canales J; Villalobos PA; Wistuba II; de Nadal E; Posas F; Gallick GE; Lin SH
    Cancer Res; 2018 Jun; 78(11):2911-2924. PubMed ID: 29514796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of miR-452-5p in the tumorigenesis of prostate cancer: A study based on the Cancer Genome Atl(TCGA), Gene Expression Omnibus (GEO), and bioinformatics analysis.
    Gao L; Zhang LJ; Li SH; Wei LL; Luo B; He RQ; Xia S
    Pathol Res Pract; 2018 May; 214(5):732-749. PubMed ID: 29559248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor removal limits prostate cancer cell dissemination in bone and osteoblasts induce cancer cell dormancy through focal adhesion kinase.
    Liu R; Su S; Xing J; Liu K; Zhao Y; Stangis M; Jacho DP; Yildirim-Ayan ED; Gatto-Weis CM; Chen B; Li X
    J Exp Clin Cancer Res; 2023 Oct; 42(1):264. PubMed ID: 37821954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics prediction and experimental verification identify MAD2L1 and CCNB2 as diagnostic biomarkers of rhabdomyosarcoma.
    Xia T; Meng L; Zhao Z; Li Y; Wen H; Sun H; Zhang T; Wei J; Li F; Liu C
    Cancer Cell Int; 2021 Nov; 21(1):634. PubMed ID: 34838000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer.
    Chen Y; Chen Z; Mo J; Pang M; Chen Z; Feng F; Xie P; Yang B
    Technol Cancer Res Treat; 2021; 20():1533033821990064. PubMed ID: 33596783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying the key genes and microRNAs in prostate cancer bone metastasis by bioinformatics analysis.
    Zhu Z; Wen Y; Xuan C; Chen Q; Xiang Q; Wang J; Liu Y; Luo L; Zhao S; Deng Y; Zhao Z
    FEBS Open Bio; 2020 Apr; 10(4):674-688. PubMed ID: 32027093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone secreted factors induce cellular quiescence in prostate cancer cells.
    Yu-Lee LY; Lee YC; Pan J; Lin SC; Pan T; Yu G; Hawke DH; Pan BF; Lin SH
    Sci Rep; 2019 Dec; 9(1):18635. PubMed ID: 31819067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of Bone Metastasis-Specific Regulation Network Based on Prognostic Stemness-Related Signatures in Prostate Cancer.
    Zhuang J; Li M; Zhang X; Xian S; Zhang J; Yin H; Liu Y; Fan M; Li Z; Zhu X; Lin R; Wang S; Zhou Z; Wei C; Yan P; Meng T; Huang R; Huang Z
    Dis Markers; 2022; 2022():8495923. PubMed ID: 35392496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPRC5A facilitates cell proliferation through cell cycle regulation and correlates with bone metastasis in prostate cancer.
    Sawada Y; Kikugawa T; Iio H; Sakakibara I; Yoshida S; Ikedo A; Yanagihara Y; Saeki N; Győrffy B; Kishida T; Okubo Y; Nakamura Y; Miyagi Y; Saika T; Imai Y
    Int J Cancer; 2020 Mar; 146(5):1369-1382. PubMed ID: 31276604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Novel Diagnostic Biomarkers in Prostate Adenocarcinoma Based on the Stromal-Immune Score and Analysis of the WGCNA and ceRNA Network.
    Zhang T; Wang Y; Dong Y; Liu L; Han Y; Wang H; Wei Q; Xia P; Ma W; Li L
    Dis Markers; 2022; 2022():1909196. PubMed ID: 35075375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization.
    Chu GC; Zhau HE; Wang R; Rogatko A; Feng X; Zayzafoon M; Liu Y; Farach-Carson MC; You S; Kim J; Freeman MR; Chung LW
    Endocr Relat Cancer; 2014 Apr; 21(2):311-26. PubMed ID: 24478054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of an Individualized Immune Prognostic Signature for Recurrent Prostate Cancer.
    Jin Y; Wang L; Lou H; Song C; He X; Ding M
    Comb Chem High Throughput Screen; 2021; 24(1):98-108. PubMed ID: 32593277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.